{
    "eid": "2-s2.0-85129323695",
    "title": "A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX\u00ae) in female school students in Thailand",
    "cover-date": "2022-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Suchada Jiamsiri",
        "Chulwoo Rhee",
        "Hyeon Seon Ahn",
        "Nimesh Poudyal",
        "Hyeong Won Seo",
        "Worrawan Klinsupa",
        "Pornjarim Nilyanimit",
        "Nakorn Premsri",
        "Chawetsan Namwat",
        "Sompong Vonpunsawad",
        "Yun Chon",
        "Sunju Park",
        "Deok Ryun Kim",
        "Elizabeth R. Unger",
        "Lauri Markowitz",
        "Yong Poovorawan",
        "Supachai Rerks-Ngarm",
        "Jean Louis Excler",
        "Julia Lynch"
    ],
    "citedby-count": 3,
    "ref-count": 27,
    "ref-list": [
        "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "A review of clinical trials of human papillomavirus prophylactic vaccines",
        "Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial",
        "Overcoming barriers to HPV vaccination: noninferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months",
        "Human papillomavirus vaccines: WHO position paper, May 2017",
        "Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials",
        "Less than 3 doses of the HPV vaccine\u2014Review of efficacy against virological and disease end points",
        "Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study",
        "Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9\u201314 Years Versus a 3-Dose Regimen in Women Aged 15\u201325 Years",
        "Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9\u201314 Years: A Randomized Trial",
        "The use of urine in the follow-up of HPV vaccine trials",
        "Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing",
        "First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected women",
        "Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan",
        "Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda",
        "Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA",
        "Development and characterization of the cobas human papillomavirus test",
        "Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment",
        "Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection",
        "Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping",
        "Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types",
        "A generalization of sampling without replacement from a finite universe",
        "Interval estimation for the difference between independent proportions: Comparison of eleven methods"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60077228",
            "affilname": "National Center for Emerging and Zoonotic Infectious Diseases",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60077228",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60068721",
            "affilname": "International Vaccine Institute, Seoul",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068721",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": null,
            "@id": "60010078",
            "affilname": "National Center for Immunization and Respiratory Diseases",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010078",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Governments of Korea",
        "International Vaccine Institute",
        "Bill & Melinda Gates Foundation"
    ]
}